{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,16]],"date-time":"2026-04-16T23:50:14Z","timestamp":1776383414909,"version":"3.51.2"},"reference-count":46,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,4,16]],"date-time":"2026-04-16T00:00:00Z","timestamp":1776297600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,4,16]],"date-time":"2026-04-16T00:00:00Z","timestamp":1776297600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100004242","name":"Princess Nourah bint Abdulrahman University","doi-asserted-by":"crossref","award":["PNURSP2026R917"],"award-info":[{"award-number":["PNURSP2026R917"]}],"id":[{"id":"10.13039\/501100004242","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-026-49288-3","type":"journal-article","created":{"date-parts":[[2026,4,16]],"date-time":"2026-04-16T21:34:17Z","timestamp":1776375257000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Bio-inspired chemometric methods for simultaneous UV spectrophotometric determination of molnupiravir, nirmatrelvir, and favipiravir in pharmaceutical formulations and environmental samples"],"prefix":"10.1038","volume":"16","author":[{"given":"Ahmed M.","family":"Abdelzaher","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Omkulthom","family":"Al kamaly","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mona A. Abdel","family":"Rahman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,4,16]]},"reference":[{"key":"49288_CR1","doi-asserted-by":"publisher","first-page":"1037","DOI":"10.1007\/s11596-021-2395-1","volume":"41","author":"L Forchette","year":"2021","unstructured":"Forchette, L., Sebastian, W. & Liu, T. A comprehensive review of COVID-19 virology, vaccines, variants, and therapeutics. Curr. Med. Sci. 41, 1037\u20131051 (2021).","journal-title":"Curr. Med. Sci."},{"key":"49288_CR2","doi-asserted-by":"publisher","first-page":"1213","DOI":"10.1016\/S0140-6736(22)01586-0","volume":"400","author":"CK Wong","year":"2022","unstructured":"Wong, C. K. et al. Real-world effectiveness of molnupiravir and nirmatrelvir plus ritonavir against mortality, hospitalisation, and in-hospital outcomes among community-dwelling, ambulatory patients with confirmed SARS-CoV-2 infection during the omicron wave in Hong Kong: An observational study. Lancet 400, 1213\u20131222 (2022).","journal-title":"Lancet"},{"key":"49288_CR3","doi-asserted-by":"publisher","first-page":"77","DOI":"10.7326\/M22-2141","volume":"176","author":"S Dryden-Peterson","year":"2023","unstructured":"Dryden-Peterson, S. et al. Nirmatrelvir plus ritonavir for early COVID-19 in a large US health system: A population-based cohort study. Ann. Intern. Med. 176, 77\u201384 (2023).","journal-title":"Ann. Intern. Med."},{"key":"49288_CR4","doi-asserted-by":"publisher","first-page":"740","DOI":"10.1038\/s41594-021-00651-0","volume":"28","author":"F Kabinger","year":"2021","unstructured":"Kabinger, F. et al. Mechanism of molnupiravir-induced SARS-CoV-2 mutagenesis. Nat. Struct. Mol. Biol. 28, 740\u2013746 (2021).","journal-title":"Nat. Struct. Mol. Biol."},{"key":"49288_CR5","doi-asserted-by":"publisher","DOI":"10.1111\/cts.13732","volume":"17","author":"BM Maas","year":"2024","unstructured":"Maas, B. M. et al. Molnupiravir: Mechanism of action, clinical, and translational science. Clin. Transl. Sci. 17, e13732 (2024).","journal-title":"Clin. Transl. Sci."},{"key":"49288_CR6","doi-asserted-by":"publisher","first-page":"1586","DOI":"10.1126\/science.abl4784","volume":"374","author":"DR Owen","year":"2021","unstructured":"Owen, D. R. et al. An oral SARS-CoV-2 Mpro inhibitor clinical candidate for the treatment of COVID-19. Science 374, 1586\u20131593 (2021).","journal-title":"Science"},{"key":"49288_CR7","doi-asserted-by":"publisher","DOI":"10.1101\/2023.05.03.23289084","author":"A Bhatia","year":"2023","unstructured":"Bhatia, A. et al. Effect of nirmatrelvir\/ritonavir (Paxlovid) on hospitalization among adults with COVID-19: An EHR-based target trial emulation from N3C. medRxiv https:\/\/doi.org\/10.1101\/2023.05.03.23289084 (2023).","journal-title":"medRxiv"},{"key":"49288_CR8","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1016\/j.ijid.2020.10.069","volume":"102","author":"S Joshi","year":"2021","unstructured":"Joshi, S. et al. Role of favipiravir in the treatment of COVID-19. Int. J. Infect. Dis. 102, 501\u2013508 (2021).","journal-title":"Int. J. Infect. Dis."},{"key":"49288_CR9","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1038\/s41422-022-00618-w","volume":"32","author":"P Li","year":"2022","unstructured":"Li, P. et al. SARS-CoV-2 Omicron variant is highly sensitive to molnupiravir, nirmatrelvir, and the combination. Cell Res. 32, 322\u2013324 (2022).","journal-title":"Cell Res."},{"key":"49288_CR10","doi-asserted-by":"publisher","first-page":"34512","DOI":"10.1039\/D2RA05066H","volume":"12","author":"AM Annadi","year":"2022","unstructured":"Annadi, A. M. et al. Development and validation of molnupiravir assessment in bulk powder and pharmaceutical formulation by the RP-HPLC-UV method. RSC Adv. 12, 34512\u201334519 (2022).","journal-title":"RSC Adv."},{"key":"49288_CR11","first-page":"57","volume":"20","author":"\u0130 Bulduk","year":"2021","unstructured":"Bulduk, \u0130. Comparison of HPLC and UV spectrophotometric methods for quantification of favipiravir in pharmaceutical formulations. Iran. J. Pharm. research: IJPR. 20, 57 (2021).","journal-title":"Iran. J. Pharm. research: IJPR"},{"key":"49288_CR12","doi-asserted-by":"publisher","DOI":"10.1016\/j.microc.2021.106917","volume":"172","author":"HM Marzouk","year":"2022","unstructured":"Marzouk, H. M., Rezk, M. R., Gouda, A. S. & Abdel-Megied, A. M. A novel stability-indicating HPLC-DAD method for determination of favipiravir, a potential antiviral drug for COVID-19 treatment; application to degradation kinetic studies and in-vitro dissolution profiling. Microchem. J. 172, 106917 (2022).","journal-title":"Microchem. J."},{"key":"49288_CR13","doi-asserted-by":"publisher","DOI":"10.1016\/j.microc.2024.111197","volume":"205","author":"HM Marzouk","year":"2024","unstructured":"Marzouk, H. M., Gouda, A. S., Rezk, M. R. & Abdel-Megied, A. M. Innovative eco-friendly stability-indicating HPLC-PDA method for simultaneous determination of the emerging antiviral drugs against COVID-19 infection molnupiravir and favipiravir; degradation kinetic studies along with LC-MS based structure elucidation. Microchem. J. 205, 111197 (2024).","journal-title":"Microchem. J."},{"key":"49288_CR14","doi-asserted-by":"publisher","DOI":"10.1016\/j.jchromb.2022.123510","volume":"1212","author":"J Martens-Lobenhoffer","year":"2022","unstructured":"Martens-Lobenhoffer, J., B\u00f6ger, C. R., Kielstein, J. & Bode-B\u00f6ger, S. M. Simultaneous quantification of nirmatrelvir and ritonavir by LC-MS\/MS in patients treated for COVID-19. J. Chromatogr. B 1212, 123510 (2022).","journal-title":"J. Chromatogr. B"},{"key":"49288_CR15","doi-asserted-by":"publisher","DOI":"10.1002\/bmc.5456","volume":"36","author":"C Liu","year":"2022","unstructured":"Liu, C. et al. Simultaneous determination of nirmatrelvir and ritonavir in human plasma using LC\u2013MS\/MS and its pharmacokinetic application in healthy Chinese volunteers. Biomed. Chromatogr. 36, e5456 (2022).","journal-title":"Biomed. Chromatogr."},{"key":"49288_CR16","doi-asserted-by":"publisher","DOI":"10.1002\/bmc.5098","volume":"35","author":"MR Rezk","year":"2021","unstructured":"Rezk, M. R., Badr, K. A., Abdel-Naby, N. S. & Ayyad, M. M. A novel, rapid and simple UPLC\u2013MS\/MS method for quantification of favipiravir in human plasma: Application to a bioequivalence study. Biomed. Chromatogr. 35, e5098 (2021).","journal-title":"Biomed. Chromatogr."},{"key":"49288_CR17","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpba.2021.114057","volume":"199","author":"MI Morsy","year":"2021","unstructured":"Morsy, M. I. et al. A novel LC-MS\/MS method for determination of the potential antiviral candidate favipiravir for the emergency treatment of SARS-CoV-2 virus in human plasma: Application to a bioequivalence study in Egyptian human volunteers. J. Pharm. Biomed. Anal. 199, 114057 (2021).","journal-title":"J. Pharm. Biomed. Anal."},{"key":"49288_CR18","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1055\/a-2061-7074","volume":"73","author":"ER Bendas","year":"2023","unstructured":"Bendas, E. R., Rezk, M. R. & Badr, K. A. Does the ethnic difference affect the pharmacokinetics of favipiravir? A pharmacokinetic study in healthy Egyptian volunteers and development of level c in-vitro in-vivo correlation. Drug Res. 73, 349\u2013354 (2023).","journal-title":"Drug Res."},{"key":"49288_CR19","doi-asserted-by":"publisher","DOI":"10.1016\/j.microc.2023.109815","volume":"197","author":"HM Marzouk","year":"2024","unstructured":"Marzouk, H. M., Gouda, A. S., Rezk, M. R. & Abdel-Megied, A. M. A validated LC-MS\/MS method for determination of molnupiravir and favipiravir in human plasma; Assessment of the remarkable potential synergistic effect against SARS-CoV-2 Infection: Application to a pharmacokinetic study in healthy Egyptian volunteers. Microchem. J. 197, 109815 (2024).","journal-title":"Microchem. J."},{"key":"49288_CR20","doi-asserted-by":"publisher","DOI":"10.1016\/j.jchromb.2022.123363","volume":"1206","author":"AS Gouda","year":"2022","unstructured":"Gouda, A. S. et al. A validated LC-MS\/MS method for determination of antiviral prodrug molnupiravir in human plasma and its application for a pharmacokinetic modeling study in healthy Egyptian volunteers. J. Chromatogr. B 1206, 123363 (2022).","journal-title":"J. Chromatogr. B"},{"key":"49288_CR21","doi-asserted-by":"publisher","first-page":"83","DOI":"10.3329\/bpj.v28i1.79468","volume":"28","author":"S Islam","year":"2025","unstructured":"Islam, S., Fariha, N. J., Ahmed, S., Faruk, O. & Rouf, A. S. S. Development and validation of UV method for routine analysis of molnupiravir. Bangladesh Pharm. J. 28, 83\u201393 (2025).","journal-title":"Bangladesh Pharm. J."},{"key":"49288_CR22","doi-asserted-by":"publisher","first-page":"2330","DOI":"10.3390\/molecules27072330","volume":"27","author":"YA Sharaf","year":"2022","unstructured":"Sharaf, Y. A., El Deeb, S., Ibrahim, A. E., Al-Harrasi, A. & Sayed, R. A. Two green micellar HPLC and mathematically assisted UV spectroscopic methods for the simultaneous determination of molnupiravir and favipiravir as a novel combined COVID-19 antiviral regimen. Molecules 27, 2330 (2022).","journal-title":"Molecules"},{"key":"49288_CR23","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-022-26944-y","volume":"13","author":"MS Imam","year":"2023","unstructured":"Imam, M. S. et al. Adjusted green HPLC determination of nirmatrelvir and ritonavir in the new FDA approved co-packaged pharmaceutical dosage using supported computational calculations. Sci. Rep. 13, 137 (2023).","journal-title":"Sci. Rep."},{"key":"49288_CR24","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-025-85776-8","volume":"15","author":"MG Yassin","year":"2025","unstructured":"Yassin, M. G., Roshdy, A. & Marie, A. A. Stability indicating RP-HPLC technique for simultaneous estimation of nirmatrelvir and ritonavir in their new copackaged dosage form for COVID-19 treatment. Sci. Rep. 15, 2281 (2025).","journal-title":"Sci. Rep."},{"key":"49288_CR25","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-025-09904-0","volume":"15","author":"MW Nassar","year":"2025","unstructured":"Nassar, M. W., Serag, A., Hasan, M. A. & Kamel, M. Development and validation of a RP-HPLC method for simultaneous determination of five COVID-19 antiviral drugs in pharmaceutical formulations. Sci. Rep. 15, 25470 (2025).","journal-title":"Sci. Rep."},{"key":"49288_CR26","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-023-44756-6","volume":"13","author":"SI Aboras","year":"2023","unstructured":"Aboras, S. I., Megahed, A. A., El-Yazbi, F. & Maher, H. M. White targeted chromatographic screening method of Molnupiravir and its metabolite with degradation kinetics characterization and in-silico toxicity. Sci. Rep. 13, 17919 (2023).","journal-title":"Sci. Rep."},{"key":"49288_CR27","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1016\/S0731-7085(02)00359-X","volume":"30","author":"E Din\u00e7","year":"2002","unstructured":"Din\u00e7, E. & Baleanu, D. Spectrophotometric quantitative determination of cilazapril and hydrochlorothiazide in tablets by chemometric methods. J. Pharm. Biomed. Anal. 30, 715\u2013723 (2002).","journal-title":"J. Pharm. Biomed. Anal."},{"key":"49288_CR28","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.saa.2017.08.066","volume":"190","author":"KAM Attia","year":"2018","unstructured":"Attia, K. A. M., El-Abasawi, N. M., El-Olemy, A. & Serag, A. Different spectrophotometric methods applied for the analysis of simeprevir in the presence of its oxidative degradation product: Acomparative study. Spectrochim. Acta A Mol. Biomol. Spectrosc. 190, 1\u20139 (2018).","journal-title":"Spectrochim. Acta A Mol. Biomol. Spectrosc."},{"key":"49288_CR29","doi-asserted-by":"publisher","DOI":"10.1016\/j.microc.2021.106638","volume":"170","author":"S Abdulwahab","year":"2021","unstructured":"Abdulwahab, S., Ali, E. E., Hassan, W. S. & Azab, S. M. Mathematically assisted UV-spectrophotometry as a greener alternative to HPLC-UV for quality control analysis of free-drug combinations. Microchem. J. 170, 106638 (2021).","journal-title":"Microchem. J."},{"key":"49288_CR30","doi-asserted-by":"crossref","unstructured":"Mostafa, A. Spectrophotometric and multivariate calibration techniques for simultaneous determination of different drugs in pharmaceutical formulations and human urine: Evaluation of greenness profile.\u00a0J. Anal. Methods Chem., 8873003. (2020).","DOI":"10.1155\/2020\/8873003"},{"key":"49288_CR31","doi-asserted-by":"publisher","DOI":"10.1186\/s13065-024-01148-9","volume":"18","author":"AA Mouhamed","year":"2024","unstructured":"Mouhamed, A. A., Nadim, A. H., Mostafa, N. M. & Eltanany, B. M. Application of smart chemometric models for spectra resolution and determination of challenging multi-action quaternary mixture: Statistical comparison with greenness assessment. BMC Chem. 18, 44 (2024).","journal-title":"BMC Chem."},{"key":"49288_CR32","doi-asserted-by":"publisher","DOI":"10.1016\/j.saa.2020.118415","volume":"238","author":"A Elsonbaty","year":"2020","unstructured":"Elsonbaty, A., Serag, A., Abdulwahab, S., Hassan, W. S. & Eissa, M. S. Analysis of quinary therapy targeting multiple cardiovascular diseases using UV spectrophotometry and chemometric tools. Spectrochim. Acta A Mol. Biomol. Spectrosc. 238, 118415 (2020).","journal-title":"Spectrochim. Acta A Mol. Biomol. Spectrosc."},{"key":"49288_CR33","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1016\/j.saa.2016.07.016","volume":"170","author":"KAM Attia","year":"2017","unstructured":"Attia, K. A. M., Nassar, M. W. I., El-Zeiny, M. B. & Serag, A. Firefly algorithm versus genetic algorithm as powerful variable selection tools and their effect on different multivariate calibration models in spectroscopy: A comparative study. Spectrochim. Acta A Mol. Biomol. Spectrosc. 170, 117\u2013123 (2017).","journal-title":"Spectrochim. Acta A Mol. Biomol. Spectrosc."},{"key":"49288_CR34","doi-asserted-by":"publisher","DOI":"10.3389\/fchem.2018.00576","volume":"6","author":"A Biancolillo","year":"2018","unstructured":"Biancolillo, A. & Marini, F. Chemometric methods for spectroscopy-based pharmaceutical analysis. Front. Chem. 6, 576 (2018).","journal-title":"Front. Chem."},{"key":"49288_CR35","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1016\/j.saa.2015.03.038","volume":"145","author":"KAM Attia","year":"2015","unstructured":"Attia, K. A. M., Nassar, M. W. I., El-Zeiny, M. B. & Serag, A. Different approaches in manipulating ratio spectra applied for the analysis of Cefprozil in presence of its alkaline-induced degradation product: A comparative study. Spectrochim. Acta A Mol. Biomol. Spectrosc. 145, 289\u2013294 (2015).","journal-title":"Spectrochim. Acta A Mol. Biomol. Spectrosc."},{"key":"49288_CR36","doi-asserted-by":"publisher","DOI":"10.1016\/j.saa.2021.120334","volume":"264","author":"A Serag","year":"2022","unstructured":"Serag, A., Hasan, M. A., Tolba, E. H., Abdelzaher, A. M. & Elmaaty, A. A. Analysis of the ternary antiretroviral therapy dolutegravir, lamivudine and abacavir using UV spectrophotometry and chemometric tools. Spectrochim. Acta A Mol. Biomol. Spectrosc. 264, 120334 (2022).","journal-title":"Spectrochim. Acta A Mol. Biomol. Spectrosc."},{"key":"49288_CR37","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1021\/ci960047x","volume":"37","author":"K Hasegawa","year":"1997","unstructured":"Hasegawa, K., Miyashita, Y. & Funatsu, K. GA strategy for variable selection in QSAR studies: GA-based PLS analysis of calcium channel antagonists. J. Chem. Inf. Comput. Sci. 37, 306\u2013310 (1997).","journal-title":"J. Chem. Inf. Comput. Sci."},{"key":"49288_CR38","doi-asserted-by":"publisher","first-page":"2092","DOI":"10.1177\/0003702817713501","volume":"71","author":"BK Lavine","year":"2017","unstructured":"Lavine, B. K. & White, C. G. Boosting the performance of genetic algorithms for variable selection in partial least squares spectral calibrations. Appl. Spectrosc. 71, 2092\u20132101 (2017).","journal-title":"Appl. Spectrosc."},{"key":"49288_CR39","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1016\/j.aca.2014.09.045","volume":"852","author":"M Goodarzi","year":"2014","unstructured":"Goodarzi, M. & dos Santos Coelho, L. Firefly as a novel swarm intelligence variable selection method in spectroscopy. Anal. Chim. Acta 852, 20\u201327 (2014).","journal-title":"Anal. Chim. Acta"},{"key":"49288_CR40","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1016\/j.aca.2010.03.048","volume":"667","author":"Z Xiaobo","year":"2010","unstructured":"Xiaobo, Z., Jiewen, Z., Povey, M. J., Holmes, M. & Hanpin, M. Variables selection methods in near-infrared spectroscopy. Anal. Chim. Acta 667, 14\u201332 (2010).","journal-title":"Anal. Chim. Acta"},{"key":"49288_CR41","doi-asserted-by":"publisher","first-page":"10076","DOI":"10.1021\/acs.analchem.0c01887","volume":"92","author":"F Pena-Pereira","year":"2020","unstructured":"Pena-Pereira, F., Wojnowski, W. & Tobiszewski, M. AGREE\u2014Analytical GREEnness metric approach and software. Anal. Chem. 92, 10076\u201310082 (2020).","journal-title":"Anal. Chem."},{"key":"49288_CR42","doi-asserted-by":"publisher","DOI":"10.3390\/analytica5030030","author":"FR Mansour","year":"2024","unstructured":"Mansour, F. R., P\u0142otka-Wasylka, J. & Locatelli, M. Modified GAPI (MoGAPI) tool and software for the assessment of method greenness: Case studies and applications. Analytica https:\/\/doi.org\/10.3390\/analytica5030030 (2024).","journal-title":"Analytica"},{"key":"49288_CR43","doi-asserted-by":"publisher","first-page":"7598","DOI":"10.1039\/D3GC02347H","volume":"25","author":"N Manousi","year":"2023","unstructured":"Manousi, N., Wojnowski, W., P\u0142otka-Wasylka, J. & Samanidou, V. Blue applicability grade index (BAGI) and software: A new tool for the evaluation of method practicality. Green Chem. 25, 7598\u20137604 (2023).","journal-title":"Green Chem."},{"key":"49288_CR44","doi-asserted-by":"publisher","DOI":"10.1186\/s13065-025-01486-2","volume":"19","author":"FR Mansour","year":"2025","unstructured":"Mansour, F. R. & Nowak, P. M. Introducing the carbon footprint reduction index (CaFRI) as a software-supported tool for greener laboratories in chemical analysis. BMC Chem. 19, 121 (2025).","journal-title":"BMC Chem."},{"key":"49288_CR45","doi-asserted-by":"publisher","DOI":"10.1016\/j.trac.2021.116223","volume":"138","author":"PM Nowak","year":"2021","unstructured":"Nowak, P. M., Wietecha-Pos\u0142uszny, R. & Pawliszyn, J. White analytical chemistry: An approach to reconcile the principles of Green Analytical Chemistry and functionality. TrAC Trends Anal. Chem. 138, 116223 (2021).","journal-title":"TrAC Trends Anal. Chem."},{"key":"49288_CR46","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpha.2024.101013","volume":"14","author":"L Yin","year":"2024","unstructured":"Yin, L. et al. Green analytical chemistry metrics for evaluating the greenness of analytical procedures. J. Pharm. Anal. 14, 101013 (2024).","journal-title":"J. Pharm. Anal."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-49288-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-49288-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-49288-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,16]],"date-time":"2026-04-16T23:03:08Z","timestamp":1776380588000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-49288-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,16]]},"references-count":46,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["49288"],"URL":"https:\/\/doi.org\/10.1038\/s41598-026-49288-3","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,16]]},"assertion":[{"value":"19 January 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"12590"}}